Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Market Cap

Niagen Bioscience has a market cap or net worth of $414.86 million as of February 26, 2026. Its market cap has decreased by -3.00% in one year.

• Market Cap: 414.86M
• Enterprise Value: 353.78M
• 1-Year Change: -3.00%
• Ranking: #3174
• Category: Small-Cap
• Stock Price: $5.18

Market Cap Chart

Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $414.86M, a decrease of -54.40%. That is a compound annual growth rate of -4.34%.

Market Cap History

Date	Market Cap	% Change
Feb 25, 2026	425.40M	-16.19%
Dec 31, 2025	507.60M	25.27%
Dec 31, 2024	405.20M	277.28%
Dec 29, 2023	107.40M	-14.15%
Dec 30, 2022	125.10M	-51.02%
Dec 31, 2021	255.40M	-13.89%
Dec 31, 2020	296.60M	15.50%
Dec 31, 2019	256.80M	35.87%
Dec 31, 2018	189.00M	-33.29%
Dec 29, 2017	283.30M	125.74%
Dec 30, 2016	125.50M	-5.71%
Dec 31, 2015	133.10M	41.45%
Dec 31, 2014	94.10M	-40.97%
Dec 31, 2013	159.40M	224.64%
Dec 31, 2012	49.10M	19.76%
Dec 30, 2011	41.00M	-49.88%
Dec 31, 2010	81.80M	544.09%
Dec 31, 2009	12.70M	-95.35%
Dec 31, 2008	272.90M	-70.00%
Jun 25, 2008	909.70M	-

View and export this data all the way back to 2008. Sign Up Today.

Related Stocks

Company	Market Cap
Upstream Bio	427.99M
Enanta Pharmaceuticals	425.28M
Armata Pharmaceuticals	421.96M
Entrada Therapeutics	412.41M
REGENXBIO	409.03M
Absci	409.01M
LENZ Therapeutics	407.08M
PureTech Health	406.95M